Drug
Olaratumab
Data on this page refer exclusively to patients treated with
Olaratumab combined with SBRT, without concurrent use of
drugs from other classes.
Combination therapy data and pooled group-level evidence are available on the
Anti-PDGFRα mAb group page.
Drug Profile
| Therapeutic Class | Monoclonal Antibodies (mAbs) |
| Drug Class | Other mAbs |
| Group | Anti-PDGFRα mAb |
| Mechanism of Action | Anti-PDGFRα antibody |
Location
Treated site
